Report Highlights
The global market for flow cytometry products is expected to grow from $5.2 billion in 2023 to $8.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2029.
Report Includes
- 31 data tables and 37 additional tables
- Analysis of the global markets for flow cytometry products, technologies and applications
- Analyses of the global market trends, with market revenue data for 2021-2022, estimates for 2023, forecasts for 2024 and 2025, and projected CAGRs through 2029
- Estimate of the current market size and revenue growth prospects, along with a market share analysis by product type, technology, application, end user and region
- Facts and figures pertaining to market drivers, opportunities and challenges, emerging technologies, regulations and the impact of macroeconomic factors
- Analysis of patents and new developments in flow cytometry technology
- Analysis of the competitive landscape, including company market shares, recent M&A activity and a venture funding outlook
- Profiles of the leading market players
Report Scope
This report aims to provide a comprehensive study of the global market for flow cytometry, both in terms of quantitative and qualitative data, to help readers develop business and growth strategies, assess the market landscape, analyze their positions in the current marketplace and make informed business decisions regarding flow cytometry products and services. BCC Research estimates market data for 2023 (the base year) and forecasts values for 2024 through 2029. Segmentation is based on technology, product, application, end user and region.
Industry growth drivers, restraints, trends and opportunities in the flow cytometry market are discussed in detail. The report also provides information on the flow cytometry market’s competitive landscape and emerging technologies. The latest news articles regarding new products, acquisitions and collaborations related to the flow cytometry market are covered in sufficient detail.
Report Synopsis
| Report Metrics | Details | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2023 | ||||||||||
| Forecast period considered | 2024-2029 | ||||||||||
| Base year market size | $5.2 billion | ||||||||||
| Market size forecast | $8.3 billion | ||||||||||
| Growth rate | CAGR of 8.2% from 2024 to 2029 | ||||||||||
| Units considered | $ Millions | ||||||||||
| Segments covered | By Product Type, Technology Type, Application, End-User, and Region | ||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) | ||||||||||
| Key Market Drivers |
|
||||||||||
| Companies studied |
|
||||||||||
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Consulting Editor’s Credentials
Dr. Marianna Tcherpakov has more than 10 years of experience as a bench scientist specializing in the areas of biochemistry, cell biology, assay development, antibody and drug manufacturing. She has authored several scientific publications in peer review journals. In the last 10 years, Marianna worked as a business development professional in CRO/CDMO industry. She is familiar with pharmaceutical and biotech landscape, trends and potential future developments in industry.
Report Highlights
The global market for flow cytometry is estimated to increase from $5.2 billion in 2022 to reach $7.6 billion by 2027, at a compound annual growth rate (CAGR) of 8.0% from 2022 through 2027.
Report Includes
- 47 data tables and 28 additional tables
- An up-to-date review and analysis of the global markets for flow cytometry products, technologies and applications
- Analyses of the global market trends, with historic market revenue (sales figures) from 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Understanding of the upcoming market potential for flow cytometry industry and innovation-driven applications of flow cytometry technology, and major regions and countries involved in market developments
- Estimation of the actual market size and revenue forecast for global flow cytometry market in USD million values, and corresponding market share analysis based on product type, technology type, application, end-user, and region
- Discussion of market dynamics that impact the growth of the market for flow cytometry products, applications in basic and clinical research, market regulations, industry structure, and penetration of technologies within the marketplace
- Review of the key patent grants on flow cytometry products and applications by each major category, along with the new developments and emerging trends in the flow cytometry market
- Competitive landscape of the leading manufacturers and suppliers of flow cytometry products, their market share analysis, financial performance, and major growth strategies within the industry
- Descriptive company profiles of leading industry players, including Agilent Technologies Inc., Beckman Coulter (Danaher Corp.), Becton, Dickinson and Co. (BD), Bio-Rad Laboratories, Merck KGaA, Miltenyi Biotec, and Thermo Fisher Scientific Inc.
Report Highlights
The global market for flow cytometry should grow from $4.6 billion in 2018 to $7.3 billion in 2023, growing at a compound annual growth rate (CAGR) of 9.7% from 2018 through 2023.
Report Includes
- 46 data tables and 13 additional tables
- An industry analysis of the products, technologies and applications of flow cytometry
- Analyses of global market trends with data from 2017 and 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2023
- Statistical data covering market projections and market shares of the global flow cytometry market by segments such as products types, technology types, applications, end users and geographical regions
- A look at the regulatory environment and growth driving factors that affect the global market
- Relevant patent analysis and number of patents issued to companies, universities, institutes, and individuals for flow cytometry products
- Comprehensive company profiles of major players of the flow cytometry market, including Beckman Coulter (Danaher Corp.), Becton Dickinson & Co., Bio-Rad Laboratories, Miltenyi Biotec, Thermo Fisher Scientific Inc., Millipore Sigma (Merck KGaA), and Luminex Corp.
Report Highlights
The global market for flow cytometry products should reach over $6.3 billion by 2020 from nearly $4.1 billion in 2015 at a compound annual growth rate (CAGR) of 9.1% from 2015 to 2020.
Report Includes
- An overview of flow cytometry products, technologies, and global markets.
- Analyses of global market trends, with data from 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020.
- Breakdowns of the flow cytometry market into segments such as instruments, reagents, software, services, technologies, applications, and end users.
- Discussions of how constraints such as increased equipment costs are hindering market growth.
- Intensive analysis with respect to top innovations, key market players and opportunities.
- Profiles of major players in the industry.
Report Highlights
The global flow cytometry products market reached $3.1 billion in 2012. This market is expected to reach nearly $3.5 billion in 2013 and about $5.7 billion in 2018, with a compound annual growth rate (CAGR) of 10.3% for the five-year period, 2013 to 2018.
Report Includes
- An overview of the flow cytometry market
- Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018
- Breakdowns of the flow cytometry market into segments such as instruments, reagents, software, services, technologies, applications, and end users
- Discussions of how constraints such as increased equipment costs are hindering market growth
- Comprehensive company profiles of major players.
Report Highlights
The global market for flow cytometry products was $2.6 billion in 2010. BCC expects this market to reach $4.3 billion by 2015 with a compound annual growth rate (CAGR) of 10.4 % between 2010 and 2015.
Related Reports
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Antibody Drugs: Technologies and Global Markets
The global market for antibody drugs is expected to grow from $242.6 billion in 2024 and is projected to reach $412.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.2% during the forecast period of 2024 to 2029.
Drug Discovery Technologies
The global market for drug discovery technologies is expected to grow from $111.9 billion in 2024 and is projected to reach $197.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.0% during the forecast period of 2024 to 2029.
Global Live Cell Imaging Market
The global market for live cell imaging is expected to grow from $2.9 billion in 2024 and is projected to reach $4.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
Recent Reports
Bioprocess Optimization and Digital Bio-manufacturing: Global Markets
The global market for bioprocess optimization and digital biomanufacturing is expected to grow from $24.3 billion in 2024 and is projected to reach $39.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2024 to 2029.
Global DNA Sequencing: Research, Applied and Clinical Markets
The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.
Artificial Intelligence (AI) in Cancer
The global market for artificial intelligence (AI) in cancer is estimated to increase from $2.2 billion in 2024 to reach $6.3 billion by 2029, at a compound annual growth rate (CAGR) of 23.1% from 2024 through 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More